imagequant (Molecular Dynamics Inc)
Structured Review
Imagequant, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imagequant+data+analysis+software/imagequant/pm17716983-118-7-11
Average 86 stars, based on 1 article reviews
Images
Related Articles
Software:Article Title: Article Snippet: .. Image analysis was performed using software Article Title: The NmpRSTU multi-component signaling system of Myxococcus xanthus regulates expression of an oxygen utilization regulon. Article Snippet: The resulting gels were exposed to the same phosphor screen overnight and then visualized on a Molecular Dynamics Storm 860 imaging system. .. Resulting images were analyzed using Article Title: Kinetic Investigation of Resistance to Islatravir Conferred by Mutations in HIV-1 Reverse Transcriptase. Article Snippet: Islatravir (EFdA) is a novel nucleoside reverse transcriptase translocation inhibitor (NRTTI) that potently blocks HIV-1 replication in vivo.. Its unique structural features in contrast to nucleoside reverse transcriptase inhibitors (NRTIs), particularly the 4 -ethynyl and 3 -hydroxy groups, contribute to its high clinical potency.. Once intracellularly activated to EFdA 5 -triphosphate (EFdA-TP), it competes with dATP for incorporation by HIV-1 reverse transcriptase (RT) during HIV-1 genomic replication. Thin Layer Chromatography:Article Title: Article Snippet: .. The products on the gels and the TLC plates were analyzed by phosphorimaging using Concentration Assay:Article Title: Kinetic Investigation of Resistance to Islatravir Conferred by Mutations in HIV-1 Reverse Transcriptase. Article Snippet: Islatravir (EFdA) is a novel nucleoside reverse transcriptase translocation inhibitor (NRTTI) that potently blocks HIV-1 replication in vivo.. Its unique structural features in contrast to nucleoside reverse transcriptase inhibitors (NRTIs), particularly the 4 -ethynyl and 3 -hydroxy groups, contribute to its high clinical potency.. Once intracellularly activated to EFdA 5 -triphosphate (EFdA-TP), it competes with dATP for incorporation by HIV-1 reverse transcriptase (RT) during HIV-1 genomic replication. |
